Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Vericel Q3 2026 Results: Net Income $14.2M, Up 179.1% YoY

Vericel Corporation reported a significant improvement in financial performance for the third quarter of 2026, with net income rising to $14.2 million compared to $5.1 million in the prior year. Total revenue for the first nine months of 2026 grew 26% to $231.3 million, driven by strong product sales, while the company transitioned from a net loss to a net income of $10.1 million for the year-to-date period.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue85.467.5
Gross profit62.649.6
Net income14.25.1
EPS (diluted, $ a share)$0.27$0.10

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+179.1%
Revenue, year on year+26.5%
Gross margin73.3%
Operating margin14.3%
Source

10-Q filed with the SEC, NASDAQ: VCEL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Vericel Corp: key numbers

Share price
$57.48Close, Nov 16
Market cap
$2.93B
Shares outstanding
51.03MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Vericel Corp

All →
8:04 PM ET Form 4
Insider Selling

Vericel CFO Joseph Anthony Mara Jr. Sells $1.46M of Stock

Joseph Anthony Mara Jr., CFO, sold 25,000 shares of Vericel Corp at $58.26 a share, worth $1.46M in total on Nov 9, 2026. Shares held after the trade: 16,186 (-60.7%).

Value
$1.46M
Shares
25,000
Price
$58.26
Role
CFO
Holding change
-60.7%
Trade date
Nov 9, 2026
7:49 PM ET Form 4
Insider Selling

Vericel Director Kevin F. Mclaughlin Sells $413K of Stock

Kevin F. Mclaughlin, Director, sold 7,000 shares of Vericel Corp at $58.96 a share, worth $413K in total on Nov 10, 2026. Shares held after the trade: 18,300 (-27.7%).

Value
$413K
Shares
7,000
Price
$58.96
Role
Director
Holding change
-27.7%
Trade date
Nov 10, 2026
7:44 PM ET Form 4
Insider Selling

Vericel Director Robert L. Zerbe Md. Sells $116K of Stock

Robert L. Zerbe Md., Director, sold 2,000 shares of Vericel Corp at $57.88 a share, worth $116K in total on Nov 9, 2026. Shares held after the trade: 32,995 (-5.7%).

Value
$116K
Shares
2,000
Price
$57.88
Role
Director
Holding change
-5.7%
Trade date
Nov 9, 2026
4:06 PM ET Form 4
Insider Selling

Vericel CFO Joseph Anthony Mara Jr. Sells $2.67M of Stock

Joseph Anthony Mara Jr., CFO, sold 50,000 shares of Vericel Corp at $53.40 to $53.73 a share (average $53.48) in 4 transactions, worth $2.67M in total between Nov 5, 2026 and Nov 6, 2026. Shares held after the trade: 16,186 (-47.4%).

Value
$2.67M
Shares
50,000
Average price
$53.48
Role
CFO
Holding change
-47.4%
Trade date
Nov 5, 2026 to Nov 6, 2026
4:06 PM ET Form 4
Insider Selling

Vericel Principal Accounting Officer Jonathan Siegal Sells $79.3K of Stock

Jonathan Siegal, Principal Accounting Officer, sold 1,500 shares of Vericel Corp at $52.90 a share, worth $79.3K in total on Nov 5, 2026. Shares held after the trade: 1,259 (-54.4%).

Value
$79.3K
Shares
1,500
Price
$52.90
Role
Principal Accounting Officer
Holding change
-54.4%
Trade date
Nov 5, 2026
4:06 PM ET Form 4
Insider Selling

Vericel CLO Sean C. Flynn Sells $779K of Stock

Sean C. Flynn, CLO, sold 15,000 shares of Vericel Corp at $51.92 a share, worth $779K in total on Nov 5, 2026. Shares held after the trade: 1,990 (-88.3%).

Value
$779K
Shares
15,000
Price
$51.92
Role
CLO
Holding change
-88.3%
Trade date
Nov 5, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.